Latest Headlines
-
Illumina And Myriad Genetics Expand Partnership To Broaden Access To HRD Testing In The United States
3/2/2023
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous recombination deficiency (HRD) testing in the United States.
-
Synergy Laboratories Taps SOPHiA GENETICS Technology For New Cancer Profiling Solution
2/28/2023
SOPHiA GENETICS, a cloud-native software company in the healthcare space, today announced that Synergy Oncology, part of Synergy Laboratories, a full-service diagnostic laboratory based in Mobile, Alabama, will use SOPHiA DDM to develop a new cancer profiling solution
-
Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test For Early Detection Of Coronary Heart Disease
2/28/2023
Cardio Diagnostics Holdings Inc, an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
- Roche Joins Forces With The U.S. Centers For Disease Control And Prevention To Strengthen Laboratory Systems In The Fight Against The HIV And Tuberculosis Epidemics 2/28/2023
-
Azenta Launches Cryo Store Pico™, A Novel Automated Cryogenic Storage System Designed For Clinical And Laboratory Applications
2/27/2023
Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the Cryo Store Pico™ ("Pico"), a novel automated cryogenic storage system designed for high-value biological samples used in the many stages of life sciences, from discovery to clinical use
-
Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With AI Powered Digital Pathology For Building The Lab Of The Future
2/27/2023
Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue, today announced the acquisition of Mountain View, CA-based Crosscope
-
Lucira Health Announces FDA Authorization Of First & Only At-Home Combination Covid-19 & Flu Test And Comments On Chapter 11 Bankruptcy Filing
2/27/2023
Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for its Lucira COVID-19 & Flu Home Test for over the counter (OTC) use at home and other non-laboratory sites
-
PerkinElmer Launches EnVison Nexus Multimode Plate Reader To Drive Improved Research And Discovery Workflows
2/24/2023
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the EnVision Nexus system, its fastest and most sensitive multimode plate reader to date, designed for demanding high-throughput screening (HTS) applications and to accelerate drug discovery efforts.
-
Chembio Announces The Receipt Of CLIA Waiver For Its DPP HIV-Syphilis System
2/24/2023
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the DPP HIV-Syphilis System.
-
Malaysian Genomics To Offer World's First DNA-Driven Fertility Test
2/23/2023
Malaysian Genomics Resource Centre Bhd [MGRC], a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic collaboration agreement with Divine Genes Sdn Bhd to collaborate on business opportunities in relation to the improvement and international distribution of genetic tests for reproductive health